{"id":"NCT00511433","sponsor":"Organon and Co","briefTitle":"Effects on Ovarian Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292003)(COMPLETED)(P05723)","officialTitle":"A Randomized, Open-Label, Comparative Trial to Evaluate the Effects on Ovarian Function of a Monophasic Combined Oral Contraceptive (COC) Containing 2.5 mg Nomegestrol Acetate (NOMAC) and 1.5 mg Estradiol (E2), Compared to a Monophasic COC Containing 3 mg Drospirenone (DRSP) and 30 ug Ethinyl Estradiol (EE)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-10","primaryCompletion":"2008-01","completion":"2008-01","firstPosted":"2007-08-03","resultsPosted":"2011-08-29","lastUpdate":"2022-02-09"},"enrollment":48,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Contraception"],"interventions":[{"type":"DRUG","name":"NOMAC-E2","otherNames":[]},{"type":"DRUG","name":"DRSP-EE","otherNames":[]}],"arms":[{"label":"NOMAC-E2","type":"EXPERIMENTAL"},{"label":"DRSP-EE","type":"ACTIVE_COMPARATOR"}],"summary":"The primary purpose of this study is to evaluate the effects of the nomegestrol acetate-estradiol (NOMAC-E2) combined oral contraceptive (COC) on ovarian function.","primaryOutcome":{"measure":"Effect on Ovarian Function as Determined by the Number of Participants With an Occurrence of Ovulation","timeFrame":"Cycle 1, Cycle 2, and Cycle 6","effectByArm":[{"arm":"NOMAC-E2","deltaMin":0,"sd":null},{"arm":"DRSP-EE","deltaMin":0,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":true,"inclusionCount":6,"exclusionCount":7},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["20695770"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":32},"commonTop":["Nasopharyngitis","Influenza","Headache","Diarrhoea","Nausea"]}}